1736 — Johnson Health Tech Co Income Statement
0.000.00%
Last trade - 00:00
- TWD25.90bn
- TWD39.71bn
- TWD38.07bn
- 79
- 41
- 94
- 87
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 25,373 | 28,367 | 30,779 | 33,613 | 38,070 |
Cost of Revenue | |||||
Gross Profit | 12,547 | 13,397 | 13,906 | 14,606 | 18,427 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 23,879 | 27,437 | 30,625 | 33,828 | 36,827 |
Operating Profit | 1,493 | 930 | 154 | -215 | 1,242 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,617 | 975 | 164 | 304 | 1,334 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,294 | 747 | 99.4 | 225 | 709 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,293 | 679 | 38.1 | 429 | 710 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,293 | 679 | 38.1 | 429 | 710 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.18 | 2.26 | 0.119 | 1.42 | 2.36 |
Dividends per Share |